0001209191-13-050241.txt : 20131101 0001209191-13-050241.hdr.sgml : 20131101 20131101190559 ACCESSION NUMBER: 0001209191-13-050241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131030 FILED AS OF DATE: 20131101 DATE AS OF CHANGE: 20131101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVY BRIAN CENTRAL INDEX KEY: 0001277458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 131187296 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-10-30 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001277458 LEVY BRIAN C/O AERIE PHARMACEUTICALS, INC. 135 U.S. HIGHWAY 206, SUITE 15 BEDMINSTER NJ 07921 0 1 0 0 Chief Medical Officer Common Stock 2013-10-30 4 P 0 6000 10.00 A 6000 D These shares of Common Stock were purchased in connection with the issuer's initial public offering (the "IPO") at the IPO price pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended, pursuant to a directed share program under which certain shares of Common Stock offered in the IPO were sold to the issuer's directors, officers, employees, consultants and other individuals associated with the issuer. /s/ Richard J. Rubino, Attorney-in-Fact for Brian Levy 2013-11-01